Memory loss and Early Dementia
More than 6 million Americans are impacted by Alzheimer’s, the most common disease with dementia as the primary symptom, and about one-third of people with MCI due to Alzheimer's disease develop dementia within 5 years of diagnosis.
In the News: Kemper Cognitive Wellness Joins Groundbreaking Clinical Trial
Kemper is honored to be one of only six functional and precision medicine practices nationwide selected to participate in this revolutionary trial. We believe its findings could reshape the future of medicine, transforming how we approach early dementia and cognitive decline.
This is a randomized, controlled clinical trial using precision medicine, which is a novel approach involving comprehensive testing along with functional and lifestyle interventions for the treatment of mild cognitive impairment or early-stage dementia. This is a completely different way of looking at and treating memory loss that impacts so many.
Candidates may have any of the below early dementia and mild cognitive impairment symptoms:
- Recently more forgetful
- Difficulty finding words
- Needs a list for everything
- Lost while walking or driving
- Difficulty with arithmetic
- Familiar tasks are difficult
Dementia Reversal Trial in Rocky River, Ohio
Applications for the Evanthea trial are now closed.
This is a revolutionary trial we believe has the potential to positively impact the future of medicine. This could change how early dementia and mild cognitive impairment are treated by looking at it from a precision medicine perspective and using lifestyle intervention.
Although the application process for this trial is now closed, Kemper Cognitive Wellness offers a variety of care models and advanced technologies to support brain health. If you have concerns about cognitive decline, we are here to help.
Contact us at info@kemperwellness.com, and our team will reach out to you.
